These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 22355905)

  • 21. Inhibiting TGF-beta signaling restores immune surveillance in the SMA-560 glioma model.
    Tran TT; Uhl M; Ma JY; Janssen L; Sriram V; Aulwurm S; Kerr I; Lam A; Webb HK; Kapoun AM; Kizer DE; McEnroe G; Hart B; Axon J; Murphy A; Chakravarty S; Dugar S; Protter AA; Higgins LS; Wick W; Weller M; Wong DH
    Neuro Oncol; 2007 Jul; 9(3):259-70. PubMed ID: 17522330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anticancer activity of vitamin E-derived compounds in murine C6 glioma cells.
    Mazzini F; Betti M; Canonico B; Netscher T; Luchetti F; Papa S; Galli F
    ChemMedChem; 2010 Apr; 5(4):540-3. PubMed ID: 20135669
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment of human glioma and medulloblastoma tumor lines in athymic mice with diaziquone and diaziquone-based drug combinations.
    Schold SC; Friedman HS; Bjornsson TD; Bigner DD
    Cancer Res; 1984 Jun; 44(6):2352-7. PubMed ID: 6722774
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of photodynamic therapy and endostatin on human glioma xenografts in nude mice.
    Zhan Q; Yue W; Hu S
    Photodiagnosis Photodyn Ther; 2011 Dec; 8(4):314-20. PubMed ID: 22122918
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autophagic cell death of malignant glioma cells induced by a conditionally replicating adenovirus.
    Ito H; Aoki H; Kühnel F; Kondo Y; Kubicka S; Wirth T; Iwado E; Iwamaru A; Fujiwara K; Hess KR; Lang FF; Sawaya R; Kondo S
    J Natl Cancer Inst; 2006 May; 98(9):625-36. PubMed ID: 16670388
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytotoxic effects of a new antitumor antibiotic, FK973, in malignant glioma.
    Moriuchi S; Shimizu K; Yamada M; Mabuchi E; Tamura K; Park KC; Hayakawa T
    Anticancer Res; 1991; 11(6):2079-84. PubMed ID: 1776843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sensitization of malignant glioma to chemotherapy through dendritic cell vaccination.
    Liu G; Black KL; Yu JS
    Expert Rev Vaccines; 2006 Apr; 5(2):233-47. PubMed ID: 16608423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glioma-specific antigens for immune tumor therapy.
    Skog J
    Expert Rev Vaccines; 2006 Dec; 5(6):793-802. PubMed ID: 17184218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antibody-based therapy for brain tumor].
    Takasu S; Yoshikawa K; Yoshida J
    Nihon Rinsho; 2005 Sep; 63 Suppl 9():563-8. PubMed ID: 16201582
    [No Abstract]   [Full Text] [Related]  

  • 30. Differential effects of PPARgamma agonists on the metabolic properties of gliomas and astrocytes.
    Spagnolo A; Grant EN; Glick R; Lichtor T; Feinstein DL
    Neurosci Lett; 2007 Apr; 417(1):72-7. PubMed ID: 17324516
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor localization of an anti-TGF-β antibody and its effects on gliomas.
    Hülper P; Schulz-Schaeffer W; Dullin C; Hoffmann P; Harper J; Kurtzberg L; Lonning S; Kugler W; Lakomek M; Erdlenbruch B
    Int J Oncol; 2011 Jan; 38(1):51-9. PubMed ID: 21109925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Immunotherapy for brain tumor: don't get "Lost in Translation"].
    Okada H
    No Shinkei Geka; 2005 May; 33(5):433-42. PubMed ID: 15912763
    [No Abstract]   [Full Text] [Related]  

  • 33. The geldanamycin analogue 17-allylamino-17-demethoxygeldanamycin inhibits the growth of GL261 glioma cells in vitro and in vivo.
    Newcomb EW; Lukyanov Y; Schnee T; Esencay M; Fischer I; Hong D; Shao Y; Zagzag D
    Anticancer Drugs; 2007 Sep; 18(8):875-82. PubMed ID: 17667592
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stimulation of TLR9 with CpG ODN enhances apoptosis of glioma and prolongs the survival of mice with experimental brain tumors.
    El Andaloussi A; Sonabend AM; Han Y; Lesniak MS
    Glia; 2006 Nov; 54(6):526-35. PubMed ID: 16906541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The therapeutic efficacy of conjugated linoleic acid - paclitaxel on glioma in the rat.
    Ke XY; Zhao BJ; Zhao X; Wang Y; Huang Y; Chen XM; Zhao BX; Zhao SS; Zhang X; Zhang Q
    Biomaterials; 2010 Aug; 31(22):5855-64. PubMed ID: 20430438
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell surface receptors in malignant glioma.
    Li YM; Hall WA
    Neurosurgery; 2011 Oct; 69(4):980-94; discussion 994. PubMed ID: 21522029
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emerging targeted treatments for malignant glioma.
    Mulholland PJ; Thirlwell C; Brock CS; Newlands ES
    Expert Opin Emerg Drugs; 2005 Nov; 10(4):845-54. PubMed ID: 16262566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SC68896, a novel small molecule proteasome inhibitor, exerts antiglioma activity in vitro and in vivo.
    Roth P; Kissel M; Herrmann C; Eisele G; Leban J; Weller M; Schmidt F
    Clin Cancer Res; 2009 Nov; 15(21):6609-18. PubMed ID: 19825946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urokinase antisense oligodeoxynucleotides as a novel therapeutic agent for malignant glioma: in vitro and in vivo studies of uptake, effects and toxicity.
    Engelhard H; Narang C; Homer R; Duncan H
    Biochem Biophys Res Commun; 1996 Oct; 227(2):400-5. PubMed ID: 8878527
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of intravenously administered recombinant vesicular stomatitis virus (VSV(deltaM51)) on multifocal and invasive gliomas.
    Lun X; Senger DL; Alain T; Oprea A; Parato K; Stojdl D; Lichty B; Power A; Johnston RN; Hamilton M; Parney I; Bell JC; Forsyth PA
    J Natl Cancer Inst; 2006 Nov; 98(21):1546-57. PubMed ID: 17077357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.